-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The growing prevalence of Alzheimer's disease (AD), the most important form of dementia, requires biomarkers that can identify AD risk as early as middle age, when preventive interventions will be more effective
prevent blood vessels
The aim of this study was to investigate whether platelet function in middle-aged adults is independently associated with future AD risk
We assessed the association between baseline platelet function and dementia risk in the community-based FHS (Framingham Heart Study) longitudinal cohort
statistics
The final study sample included 1847 FHS participants (mean age 53.
hypertension
CONCLUSIONS: At 20 years of follow-up, individuals with no antiplatelet therapy and higher platelet responses had a higher risk of dementia later in life, underscoring the role of platelet function in AD risk
Individuals not receiving antiplatelet therapy and with higher platelet responses have a higher risk of dementia later in life, underscoring the role of platelet function in AD risk
Original source:
Jaime Ramos‐Cejudo.